Broccoli, Alessandro; Argnani, Lisa; Cross, Matthew; Janus, Agnieszka; Maitre, Elsa; Troussard, Xavier; Robak, Tadeusz; Dearden, Claire; Else, Monica; Catovsky, Daniel; Zinzani, Pier Luigi, A 3-decade multicenter European experience with cladribine as upfront treatment in 384 hairy cell leukemia patients, «BLOOD ADVANCES», 2022, 6, pp. 4224 - 4424 [articolo]Open Access
Giladi O.; Bagnato G.; Gentilini M.; Shimony S.; Pasvolsky O.; Berger T.; Itchaki G.; Raanani P.; Broccoli A.; Stefoni V.S.; Lolli G.; Argnani L.; Zinzani P.L.; Gurion R., ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2022, 22, pp. 370 - 371 [articolo]
Lolli, Ginevra; Ursi, Margherita; Dicataldo, Michele; Casadei, Beatrice; Storci, Gianluca; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi, Allogeneic stem cell transplantation is capable of healing a case of bone marrow aplasia following CAR-T cell therapy in a lymphoma patient, «LEUKEMIA & LYMPHOMA», 2022, Epub ahead of print, pp. 1 - 3 [articolo]
Alderuccio, Juan Pablo; Arcaini, Luca; Watkins, Marcus P; Beaven, Anne W; Shouse, Geoffrey; Epperla, Narendranath; Spina, Michele; Stefanovic, Alexandra; Sandoval-Sus, Jose; Torka, Pallawi; Alpert, Ash B; Olszewski, Adam J; Kim, Seo-Hyun; Hess, Brian; Gaballa, Sameh; Ayyappan, Sabarish; Castillo, Jorge J; Argnani, Lisa; Voorhees, Timothy J; Saba, Raya; Chowdhury, Sayan Mullick; Vargas, Fernando; Reis, Isildinha M; Kwon, Deukwoo; Alexander, Jonathan S; Zhao, Wei; Edwards, Dali; Martin, Peter; Cencini, Emanuele; Kamdar, Manali; Link, Brian K; Logothetis, Constantine N; Herrera, Alex F; Friedberg, Jonathan W; Kahl, Brad S; Luminari, Stefano; Zinzani, Pier Luigi; Lossos, Izidore S, An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma, «BLOOD ADVANCES», 2022, 6, pp. 2035 - 2044 [articolo]Open Access
Stefoni V.; Argnani L.; Carella M.; Casadei B.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Coppola P.E.; Zinzani P.L., BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience, «JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]Open Access
Stefoni, V.; Pellegrini, C.; Argnani, L.; Corradini, P.; Dodero, A.; Orsucci, L.; Volpetti, S.; Zinzani, P. L., Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 307 - 309 [articolo]
Zanetti, Anna; Sakellariou, Garifallia; Zambon, Antonella; Carrara, Greta; Argnani, Lisa; Mantovani, Lorenzo G; Cortesi, Paolo A; Bugatti, Serena; Montecucco, Carlomaurizio; Scirè, Carlo A, Cost-effectiveness of the early arthritis clinic organizational model: the ELECTRA study, «ARTHRITIS CARE & RESEARCH», 2022, Epub ahead of print, pp. 1 - 6 [articolo]Open Access
Nanni, Laura; Musuraca, Gerardo; Morigi, Alice; Stefoni, Vittorio; Barone, Monica; Conti, Gabriele; Fabbrini, Marco; Turroni, Silvia; Broccoli, Alessandro; Argnani, Lisa; Brigidi, Patrizia; Zinzani, Pier Luigi, Design of New Personalized Therapeutic Approaches for Diffuse Large B-Cell Lymphoma through Gut Microbiome Profiling, «BLOOD», 2022, 140, pp. 4961 - 4963 [abstract]
Broccoli A.; Terragna C.; Nanni L.; Martello M.; Armuzzi S.; Agostinelli C.; Morigi A.; Casadei B.; Pellegrini C.; Stefoni V.; Sabattini E.; Argnani L.; Zinzani P.L., Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 57 - 62 [articolo]Open Access
Broccoli, A.; Terragna, C.; Nanni, L.; Martello, M.; Armuzzi, S.; Agostinelli, C.; Morigi, A.; Casadei, B.; Pellegrini, C.; Stefoni, V.; Sabattini, E.; Argnani, L.; Zinzani, P. L., Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia, «HEMATOLOGICAL ONCOLOGY», 2022, 40, pp. 57 - 62 [articolo]Open Access
Argnani, Lisa, "First Twin Live-Birth Deliver After Oocyte Cryopreservation in a Follicular Lymphoma Patient", «BIOMEDICAL JOURNAL OF SCIENTIFIC & TECHNICAL RESEARCH», 2022, 41, pp. 0 - 0 [articolo]
Lolli, Ginevra; Casadei, Beatrice; Stefoni, Vittorio; Argnani, Lisa; Bonifazi, Francesca; Zinzani, Pier Luigi, Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation, «CHEMOTHERAPY», 2022, 67, pp. 253 - 255 [articolo]
Argnani, L.; Casadei, B.; Pelusi, C.; Lo Preiato, V.; Pagotto, U.; Bertoni, F.; Zinzani, P. L., Immune-related adverse events in the treatment of non-Hodgkin lymphoma with immune checkpoint inhibitors, «SCIENTIFIC REPORTS», 2022, 12, Article number: 1753, pp. 1753 - 1759 [articolo]Open Access
Carrara G.; Argnani L.; Zanetti A.; Zabotti A.; Silvagni E.; Sebastiani G.D.; Sebastiani M.; Scire C.A., Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology, «SCANDINAVIAN JOURNAL OF RHEUMATOLOGY», 2022, Online ahead of print, pp. 1 - 5 [articolo]
Broccoli, Alessandro; Argnani, Lisa; Coppola, Paolo Elia; Gentilini, Marianna; Bagnato, Gianmarco; Lolli, Ginevra; Carella, Matteo; Nanni, Laura; Morigi, Alice; Casadei, Beatrice; Pellegrini, Cinzia; Stefoni, Vittorio; Zinzani, Pier Luigi, Prolonged responses to brentuximab vedotin as last therapy in Hodgkin lymphoma failing autologous transplantation: A case series, «TUMORI», 2022, Online ahead of print, pp. 3008916221090327 - 3008916221090327 [articolo]
